8-K - RAPT Therapeutics, Inc. | StockGist

Current Report Details

Event Type

Regulation Fd

Exhibits Only

Disclosure

Voluntary

Variant

8-K

Items Reported

7.01

Regulation FD Disclosure. On January 14, 2026, RAPT Therapeutics, Inc. (the “Company”) will participate in the 44th Annual J.P. Morgan Healthcare Conference (th

Regulation Fd

9.01

Financial Statements and Exhibits. Exhibit No. Description 99.1 Corporate Presentation 104 Cover Page Interactive Data File (embedded within the Inline XBRL doc

Exhibits Only

Source Document

Exhibits (2)

8-K

99.1

EX-99.1